U.S. market Closed. Opens in 11 hours 35 minutes

NXTC | NextCure, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
RevenueN/AN/AN/A22.38M6.35MN/AN/A
Cost of Revenue3.68M4.48M4.30M46.55K34.22KN/AN/A
Gross Profit-3.68M-4.48M-4.30M22.33M6.31MN/AN/A
Operating Expenses63.95M75.91M70.77M63.60M43.83M23.20M15.55M
Selling, General & Admin16.02M21.71M20.57M17.05M9.61M3.41M2.60M
Research & Development47.93M54.20M50.19M46.55M34.22M19.79M12.95M
Other Operating ExpensesN/A1.18M1.38M4.62M3.75M397.00KN/A
Operating Income-67.64M-75.91M-70.77M-41.23M-37.48M-23.20M-15.55M
Other Expenses / Income4.91M1.18M1.38M4.62M3.75M397.00K80.00K
Before Tax Income-62.72M-74.73M-69.39M-36.60M-33.74M-22.80M-15.47M
Income Tax ExpensesN/A-5.30M6.96M-3.41M2.52M397.00KN/A
Net Income-62.72M-69.43M-69.39M-33.19M-33.74M-22.80M-15.47M
Interest ExpensesN/A-5.30M77.00K183.00K209.00KN/AN/A
Basic Shares Outstanding27.84M27.74M27.62M27.53M15.70M10.04M10.04M
Diluted Shares Outstanding27.84M27.74M27.62M27.53M15.70M10.04M10.04M
EBITDA-63.95M-75.91M-63.57M-41.23M-34.79M-21.52M-14.89M
EBITDA Margin0.00%0.00%0.00%-184.22%-548.20%0.00%0.00%
EBIT-62.72M-80.03M-62.35M-36.42M-31.01M-22.40M-15.47M
EBIT Margin0.00%0.00%0.00%-162.75%-488.61%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙